Clinical implications of hyperprogression with immune checkpoint inhibitors in patients with head and neck squamous cell carcinoma (HNSCC).

Panagiota Economopoulou, Amanda Psyrri, George Papaxoinis et al.|Journal of Clinical Oncology|2019

Cited by 4